Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesiveness of Rotigotine Patch Formulations in Parkinson's Disease
NCT02230904Phase 1Completed
- Sponsor
- UCB
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rotigotine in Parkinson's disease (PD) (2 arms), sponsored by UCB. Primary endpoint: Average Adhesiveness Score According to EMA Draft Guideline at Day 5. Started Sep 2014; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02230904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02230904.